STK33 Antibody (monoclonal) (M09)
Mouse monoclonal antibody raised against a full length recombinant STK33.
- 产品详情
- 实验流程
Application ![]()
| WB, IF, IP |
---|---|
Primary Accession | Q9BYT3 |
Other Accession | BC031231 |
Reactivity | Human, Mouse, Rat |
Host | mouse |
Clonality | monoclonal |
Isotype | IgG1 Kappa |
Clone Names | 1F10 |
Calculated MW | 57831 Da |
Gene ID | 65975 |
---|---|
Other Names | Serine/threonine-protein kinase 33, STK33 |
Target/Specificity | STK33 (AAH31231, 1 a.a. ~ 514 a.a) full-length recombinant protein with GST tag. MW of the GST tag alone is 26 KDa. |
Dilution | WB~~1:500~1000 IF~~1:50~200 IP~~N/A |
Format | Clear, colorless solution in phosphate buffered saline, pH 7.2 . |
Storage | Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing. |
Precautions | STK33 Antibody (monoclonal) (M09) is for research use only and not for use in diagnostic or therapeutic procedures. |
For Research Use Only. Not For Use In Diagnostic Procedures.
Provided below are standard protocols that you may find useful for product applications.
REFERENCES
1.STK33 Kinase Activity is Non-Essential in KRAS-Dependent Cancer Cells.Babij C, Zhang Y, Kurzeja RJ, Munzli A, Shehabeldin A, Fernando M, Quon K, Kassner PD, Ruefli-Brasse AA, Watson VJ, Fajardo F, Jackson A, Zondlo J, Sun Y, Ellison AR, Plewa CA, San Miguel T, Robinson J, McCarter J, Schwandner R, Judd T, Carnahan J, Dussault I.Cancer Res. 2011 Jul 8. [Epub ahead of print]2.Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells.Scholl C, Frohling S, Dunn IF, Schinzel AC, Barbie DA, Kim SY, Silver SJ, Tamayo P, Wadlow RC, Ramaswamy S, Dohner K, Bullinger L, Sandy P, Boehm JS, Root DE, Jacks T, Hahn WC, Gilliland DG.Cell. 2009 May 29;137(5):821-34.

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。
如有疑问,联系:0512-88856768 tech-china@abcepta.com.